Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessing depression in geriatric cancer patients: Do we have appropriate measures?
    Meeting Abstract

    Nelson, C.; Holland, J.; Bhaskaran, V.; Balk, E.; Traina, T.; Arti, H.; Roth, A.
    Psycho-Oncology (2008)

    Fulltext@MSK | Save
  • Tanespimycin (17-allylamino-17-demethoxy-geldanamycin; 17-AAG) in breast cancer
    Meeting Abstract

    Modi, S.; Sugarman, S.; Stopeck, A.; Linden, H.; Ma, W.; Chandarlapaty, S.; Solit, D.; Norton, L.; Rosen, N.; Kersey, K.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Retrospective analysis of biochemical markers of bone turnover in oncologic patients who developed osteonecrosis of the jaw
    Meeting Abstract

    Farooki, A.; Fornier, M.; Estilo, C.
    Clinical and Experimental Metastasis (2008)

    Fulltext@MSK | Save
  • Dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2 overexpressed/amplified breast cancer (BC): First safety results
    Meeting Abstract

    Dang, C.; Lin, N.; Lake, D.; Theodoulou, M.; Drullinsky, P.; Gorsky, M.; Chen, C.; Norton, L.; Winer, E.; Hudis, C.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Standard fractionation radiation: Local control and survival for inflammatory breast cancer
    Meeting Abstract

    Damast, S.; Ho, A. Y.; Montgomery, L.; Fornier, M. N.; Beal, K.; Elkin, E.; Ishill, N.; McCormick, B.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Tris (dibenzylideneacetone) dipalladium (Tris DBA), an N-myristoyltransferase 1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Meeting Abstract

    Arbiser, I. L.; Bhandarkar, S.; Bromberg, J.; Selvakumar, P.; Sharma, R. K.; Fried, L.; Govindarajan, B.
    Journal of Investigative Dermatology (2008)

    Fulltext@MSK | Save
  • Breast
    Journal Article

    Seidman, A. D.
    Oncology (Norwalk) (2008)

    Fulltext@MSK | Save
  • Treatment strategies for patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Journal Article

    Seidman, A. D.
    Seminars in Oncology (2008)

    Fulltext@MSK | Save
  • Racial differences in clinical outcomes from metastatic breast cancer: A pooled analysis of CALGB 9342 and 9840 - Cancer and Leukemia Group B
    Journal Article

    Polite, B. N.; Cirrincione, C.; Fleming, G. F.; Berry, D. A.; Seidman, A.; Muss, H.; Norton, L.; Shapiro, C.; Bakri, K.; Marcom, K.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
    Journal Article

    Perez, E. A.; Suman, V. J.; Davidson, N. E.; Sledge, G. W.; Kaufman, P. A.; Hudis, C. A.; Martino, S.; Gralow, J. R.; Dakhil, S. R.; Ingle, J. N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save